# A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

> **NCT00961350** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 530 (actual)

## Conditions studied

- Gastric Ulcer

## Interventions

- **DRUG:** PA32540
- **DRUG:** EC Aspirin 325

## Key facts

- **NCT ID:** NCT00961350
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 530 (ACTUAL)
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961350, "A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00961350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*